Refine your search
1,186 results found
About Davies Collison Cave Davies Collison Cave is Australia’s leading intellectual property legal practice, with a history that goes back nearly 140…
Davies Collison Cave | Australia | 6 Mar 2023
Greenwashing - ACCC releases initial findings from online review of Australian businesses
On 2 March 2023, the Australian Competition and Consumer Commission (ACCC) released its findings of its internet sweep of environmental claims as…
Davies Collison Cave | Australia, New Zealand | 5 Mar 2023
New Zealand trade mark case demonstrates a difference in evidence admissibility between Australia and New Zealand
A recent New Zealand trade mark opposition decision indicates just how difficult it is to lodge evidence “out of time”, demonstrating a distinction…
Davies Collison Cave | Australia, Singapore | 3 Mar 2023
Sufficiency of disclosure: New considerations under Singapore patent law
Sufficiency of disclosure is a cornerstone of patent law and is part of a “patent bargain” for providing a limited-term monopoly over an invention…
Davies Collison Cave | European Union | 27 Feb 2023
Unified Patent Court and Unitary Patent - Opting Out!
On 1 June 2023, a new Unified Patent Court (UPC) and Unitary Patent (UP) will come into effect, leaving European patent holders with a number of…
Davies Collison Cave | Australia | 24 Feb 2023
Batteries to lead the charge in the Green Energy Revolution
A generational energy transition is currently underway on a global scale, promising to be the dawn of a new industrial age. Worldwide investment in…
Davies Collison Cave | Hong Kong | 9 Feb 2023
Hong Kong Drug Registration, Patent Linkage, Patent Term Extension, and Bolar Provisions - A taste of “One Country, Two Systems”
As a Special Administration Region (SAR) of China, Hong Kong still retains much of the basic common law and legal system that was established under…
Davies Collison Cave | Australia | 6 Feb 2023
Australia to legalize the therapeutic use of psilocybine and MDMA
In a decision released on 3 February 2023, the Australian Therapeutic Goods Administration (TGA) have agreed to amend the Poisons Standard to include…
Davies Collison Cave | Singapore | 31 Jan 2023
The consequences of failure to follow a strict evidentiary process in Singapore
Chen & Partners (S) Pte Ltd v Soon Ailing [2023] SGIPOS 3 (“Ailing v Chen”) concerned revocation of a design registered to Chen & Partners (S) Pte…
Davies Collison Cave | China, Hong Kong | 15 Jan 2023
Hong Kong applicants to receive Prioritised Patent Examinations by Chinese Patent Office (CNIPA) in new Pilot Program
The Chinese and Hong Kong IP offices (CNIPA and HKIPD) have announced a pilot project for prioritised examination of Mainland Chinese invention…
Davies Collison Cave | Hong Kong | 10 Jan 2023
Hong Kong Government bans CBD from 1 Feb 2023
As from 1 February 2023 Hong Kong will ban cannabidiol (CBD), including all Products Containing CBD. CBD will be added to the Dangerous Drugs…
